Premedication for Non-Emergency Endotracheal Intubation In the NICU

Status Completed

Clinical Trial Summary

Those infants who received the muscle relaxation in combination with the vagolytic (reduce vagus nerve impulses) and pain medication will have reduced time to successful intubation (placement of tube into the lungs), a decrease in the number of attempts, and better intubation conditions reported by the practitioner. The objectives of the study include: 1.) Does the medication protocol outlined in this study provide optimal intubation conditions? (i.e.good jaw relaxation, open and immobile vocal cords and suppression of gag reflex) 2.) Does the addition of a muscle relaxant prior to intubation contribute to less attempts and achieving successful intubation as opposed to neonates who do not receive the muscle relaxant.

Clinical Trial Description

The investigators project will study two different strategies of pre-medication in an attempt to eliminate the pain and discomfort associated with the elective intubation procedure. The study will be blinded and patients will be randomized in two different arms according to gestational age and identified by study number for pre-medication protocols. Demographic as well as study information prior, during and post intubation attempt will be recorded and closely monitored. Each patient will be monitored for study purposes for at least 24 hours after intubation attempt to record any potential side effects of the medication. The investigators plan to have a data safety monitoring board established composed of three pediatric doctors / specialists not associated with this study.

The response of paralysis, onset and duration will be assessed clinically. Onset of muscle relaxation will be described as the absence of spontaneous movements and flaccidity, measured in seconds from the end of the medication administration. Duration of paralysis will be determined by the difference in time from the onset of paralysis to the return of spontaneous movements and pre-intubation tone ;

Study Design

Related Conditions & MeSH terms

Respiratory Distress Syndrome
Respiratory Distress Syndrome, Adult
Respiratory Distress Syndrome, Newborn

Clinical Trial Details

NCT number	NCT01749501
Study type	Interventional
Source	William Beaumont Hospitals
Contact
Status	Completed
Phase	Phase 4
Start date	January 2011
Completion date	January 2014

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06168149` - The Relationship of Fetal Lung Elastography Values With the Development of Respiratory Distress in Cases of Preterm Labor
Recruiting	`NCT03670732` - CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure	N/A
Recruiting	`NCT02901652` - NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome	N/A
Completed	`NCT02249143` - Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants	N/A
Suspended	`NCT01852916` - NHFOV Versus NCPAP to Prevent Exubation Failure	N/A
Completed	`NCT00208039` - Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates	N/A
Recruiting	`NCT03510169` - Use of Gentle Synchronized Negative Pressure in Helping Babies Breathe	N/A
Completed	`NCT00004494` - Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis	Phase 1
Completed	`NCT00006058` - Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns	N/A
Completed	`NCT00004805` - Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death	N/A
Completed	`NCT03292562` - A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation	N/A
Completed	`NCT05948332` - Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation
Completed	`NCT05038514` - The Effect of Music Therapy in COVID-19 Patients Given Prone Position	N/A
Active, not recruiting	`NCT04079829` - Postoperative Respiratory Abnormalities
Completed	`NCT05462509` - Feasibility of Use of the PATH bCPAP and Oxygen Blenders Device With Neonates in Uganda	N/A
Active, not recruiting	`NCT03808402` - The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
Completed	`NCT01812681` - Cord Blood 25(oh)-Vitamin D Level in Preterm Infants and Associated Morbidities	N/A
Not yet recruiting	`NCT01440868` - Sustained Lung Inflation in the Delivery Room in Preterm Infants at High Risk of Respiratory Distress Syndrome	N/A
Completed	`NCT01517958` - Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates	N/A
Completed	`NCT01222247` - Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.